You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 10, October 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Head and Neck Liposarcoma

A Histopathologic Reevaluation of Reported Cases

Timothy M. McCulloch, MD; Kathleen H. Makielski, MD; Michael A. McNutt, MD

Arch Otolaryngol Head Neck Surg. 1992;118(10):1045-1049.


Abstract

• Head and neck liposarcoma is an extremely rare tumor. As with all rare lesions there is a void in the literature regarding tumor activity and treatment response. It is difficult to make rational treatment plans and advise patients as to probable treatment response and prognosis. To obtain as much info mation as possible from available data we have reviewed the world literature and reevaluated the descriptive histopathologic findings and treatment response of reported cases. Seventy-six cases have been reported since 1911. We added another case and then reclassified the previously reported lesions according to a current histopathologic system (welldifferentiated, myxoid, round-cell, and pleomorphic lesions). We assessed tumor activity and treatment response by histopathologic tumor type. Paralleling tumor activity in other anatomic regions, all patients with myxoid and welldifferentiated tumors did well; all were alive at the end of follow-up, eight of eight and 11 of 11, respectively (average follow-up, 5.7 and 4.8 years). This is compared with a 50% mortality rate in the round-cell and pleomorphic groups by the end of 2 years, (two of three and six of 11 patients alive, respectively). The likelihood of recurrence correlated with extent of tumor removal, and metastatic disease was identified almost exclusively with the tumor of the round-cell and pleomorphic variants. Surgical excision remains the primary treatment modality, while radiation and chemotherapy appear to be of limited utility.

(Arch Otolaryngol Head Neck Surg. 1992;118:1045-1049)



Author Affiliations

From the Department of Otolaryngology Head-Neck Surgery, University of Iowa, Iowa City (Dr McCulloch); Department of Otolaryngology Head-Neck Surgery, University of Washington, Seattle (Dr Makielski); and Laboratory of Pathology of Seattle (Wash) (Dr McNutt).


Footnotes

Accepted for publication June 5, 1992.

Presented at the Western Section of the Triological Society, Spanish Bay, Calif, January 5, 1990.

Reprint requests to the Department of Otolaryngology Head-Neck Surgery, University of Iowa, Iowa City, IA 52242 (Dr McCulloch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Liposarcoma of the sinonasal tract
THOMPSON et al.
Br. J. Radiol. 2009;82:e160-e163.
ABSTRACT | FULL TEXT  

Radiology Quiz Case 2--Diagnosis
Arch Otolaryngol Head Neck Surg 2003;129:132-133.
FULL TEXT  

Dedifferentiated Liposarcoma of the Pyriform Sinus: Report of a Case and Review of the Literature
Gonzalez-Lois et al.
INT J SURG PATHOL 2002;10:75-79.
ABSTRACT  

Laryngeal Liposarcoma
Podoshin et al.
Arch Otolaryngol Head Neck Surg 1993;119:1383-1384.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.